Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria
Ann Rheum Dis
.
2018 Aug;77(8):e50.
doi: 10.1136/annrheumdis-2017-212368.
Epub 2017 Sep 25.
Authors
Lorenzo Cavagna
1
,
Santos Castañeda
2
3
,
Carlo Sciré
4
,
Miguel A Gonzalez-Gay
5
;
AENEAS Collaborative Group Members
Affiliations
1
Department of Rheumatology, University and IRCCS Foundation Policlinico S. Matteo, Pavia, Italy.
2
Department of Rheumatology, Hospital Universitario La Princesa, Madrid, Spain.
3
Department of Rheumatology, FJD, Madrid, Spain.
4
Dipartimento di Scienze Mediche, Universita degli Studi di Ferrara, Ferrara, Emilia-Romagna, Italy.
5
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
PMID:
28970214
DOI:
10.1136/annrheumdis-2017-212368
No abstract available
Keywords:
disease activity; patient perspective; treatment.
Publication types
Letter
Comment
MeSH terms
Autoantibodies
Humans
Myositis*
Registries
Substances
Autoantibodies
Supplementary concepts
Antisynthetase syndrome